JP2023545501A5 - - Google Patents

Info

Publication number
JP2023545501A5
JP2023545501A5 JP2023522978A JP2023522978A JP2023545501A5 JP 2023545501 A5 JP2023545501 A5 JP 2023545501A5 JP 2023522978 A JP2023522978 A JP 2023522978A JP 2023522978 A JP2023522978 A JP 2023522978A JP 2023545501 A5 JP2023545501 A5 JP 2023545501A5
Authority
JP
Japan
Prior art keywords
antibody
seq
amino acid
acid sequence
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023522978A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023545501A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/055216 external-priority patent/WO2022081997A1/en
Publication of JP2023545501A publication Critical patent/JP2023545501A/ja
Publication of JP2023545501A5 publication Critical patent/JP2023545501A5/ja
Pending legal-status Critical Current

Links

JP2023522978A 2020-10-16 2021-10-15 血液障害を処置するための組成物及び方法 Pending JP2023545501A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063093029P 2020-10-16 2020-10-16
US63/093,029 2020-10-16
PCT/US2021/055216 WO2022081997A1 (en) 2020-10-16 2021-10-15 Compositions and methods for treating blood disorders

Publications (2)

Publication Number Publication Date
JP2023545501A JP2023545501A (ja) 2023-10-30
JP2023545501A5 true JP2023545501A5 (https=) 2024-10-22

Family

ID=81208704

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023522978A Pending JP2023545501A (ja) 2020-10-16 2021-10-15 血液障害を処置するための組成物及び方法

Country Status (8)

Country Link
US (1) US20230391858A1 (https=)
EP (1) EP4228696A4 (https=)
JP (1) JP2023545501A (https=)
KR (1) KR20230087572A (https=)
AU (1) AU2021361067A1 (https=)
CA (1) CA3195798A1 (https=)
MX (1) MX2023004429A (https=)
WO (1) WO2022081997A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3019240T3 (da) 2013-07-09 2024-06-03 Annexon Inc Anti-komplementfaktor C1Q antistoffer og anvendelser deraf
US12486322B2 (en) * 2021-12-13 2025-12-02 Annexon, Inc. Anti-complement factor C1q antibodies with single binding arms and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3019240T3 (da) * 2013-07-09 2024-06-03 Annexon Inc Anti-komplementfaktor C1Q antistoffer og anvendelser deraf
SI3215527T1 (sl) * 2014-11-05 2025-04-30 Annexon, Inc. Humanizirana protitelesa proti komplementnemu faktorju C1q in njihova uporaba
EP3380518B1 (en) * 2015-11-24 2026-03-25 Annexon, Inc. Anti-complement factor c1q fab fragments and uses thereof
BR112022007051A2 (pt) * 2019-10-17 2022-07-05 Annexon Inc Composições e métodos para tratamento de distúrbios hematológicos

Similar Documents

Publication Publication Date Title
JP2022551751A5 (https=)
JP7042467B2 (ja) 単鎖可変フラグメントcd3結合タンパク質
JP7101621B2 (ja) 単一ドメイン血清アルブミン結合タンパク質
US10618976B2 (en) SIRP-α agonist antibody
JP6262715B2 (ja) ヒト化およびキメラ抗c3因子抗体、ならびにその使用
KR101941514B1 (ko) 개선된 반감기를 가지는 변형된 항체
JP6244350B2 (ja) ヒト化およびキメラ抗因子Bb抗体、ならびにその使用
JP2018520139A (ja) エクリズマブまたはエクリズマブバリアントでのワクチン接種に従って患者を処置するための方法
JP2020511469A5 (https=)
KR102896085B1 (ko) 인자 h 강화 항체 및 이의 사용
JP2023545501A5 (https=)
JP2024518844A5 (https=)
CN116554323B (zh) 人源化抗il21抗体的开发和应用
TW202214701A (zh) 抗FXI/FXIa抗體、其抗原結合片段及醫藥用途
CN114828886A (zh) 因子h增强抗体及其用途
KR20170058922A (ko) 인자 h 강화 항체 및 그의 용도
JP7735545B2 (ja) Cdcプラットホーム抗体
RU2834783C2 (ru) Антитело b7h6 и его применение
WO2025045251A2 (en) Multispecific constructs comprising anti-factor d moiety
JP6737482B1 (ja) 抗ポドプラニン抗体
KR20250077505A (ko) 항-c1q 항체를 위한 제형
TW202604960A (zh) 一種治療膜性腎病變的拮抗劑及其用途
JP2024545741A (ja) 単一特異性および二重特異性抗体ならびにその抗原結合断片
IL323175A (en) Human complement component 2 binding molecules
JP2023507852A5 (https=)